EVALUATION OF THE SAFETY, TOLERABILITY, EFFICACY AND ACTIVITY OF AMX0035, A FIXED COMBINATION OF PHENYLBUTYRATE (PB) AND TAUROURSODEOXYCHOLIC ACID (TUDCA), FOR TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS)

UT Health San Antonio

The UT Health San Antonio, with missions of teaching, research and healing, is one of the country’s leading health sciences universities.

Principal Investigator(s)

Jackson, Carlayne E

Funded by

MASSACHUSETTS GENERAL HOSPITAL

Research Start Date

05/01/2018

Status

Active

Collaborative Project

Clinical Care

Drug Discovery

Other

Bioscience Research Panel